CymaBay Therapeutics
Why Robinhood?
You can watch CBAY and buy or sell other stocks, ETFs, and their options commission-free!About CBAY
CymaBay Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the provision and development of access to therapies for patients with liver and other chronic diseases with high unmet medical needs. Its products pipeline includes Seladelpar, MBX-2982, CB-0406, and CB-001.
CBAY Key Statistics
Stock Snapshot
CymaBay Therapeutics(CBAY) stock is priced at $32.48, giving the company a market capitalization of 3.73B. It carries a P/E multiple of -32.75.
On 2026-02-15, CymaBay Therapeutics(CBAY) stock opened at —, reached a high of —, and a low of —.
CymaBay Therapeutics(CBAY) shares are trading with a volume of 0, against a daily average of 1.85M.
In the last year, CymaBay Therapeutics(CBAY) shares hit a 52-week high of $32.50 and a 52-week low of $7.26.
In the last year, CymaBay Therapeutics(CBAY) shares hit a 52-week high of $32.50 and a 52-week low of $7.26.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.